These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2499914)

  • 41. Flumazenil in the treatment of hepatic encephalopathy.
    Howard CD; Seifert CF
    Ann Pharmacother; 1993 Jan; 27(1):46-8. PubMed ID: 8431621
    [No Abstract]   [Full Text] [Related]  

  • 42. [GABA-benzodiazepine receptor complex: therapeutic role of benzodiazepine antagonists].
    Andresen M; Arrese M; Dougnac A; Godoy J; Prat G; Chianale J
    Rev Med Chil; 1989 Aug; 117(8):944-6. PubMed ID: 2562414
    [No Abstract]   [Full Text] [Related]  

  • 43. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of acute and chronic hepatic encephalopathy in cirrhosis].
    Doffoel M; Bockel R
    Ann Gastroenterol Hepatol (Paris); 1984; 20(3):163-6. PubMed ID: 6529174
    [No Abstract]   [Full Text] [Related]  

  • 45. Benzodiazepine antagonist in the treatment of human hepatic encephalopathy.
    Ferenci P; Grimm G
    Adv Exp Med Biol; 1990; 272():255-65. PubMed ID: 2103692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Forms of hepatic failure in patients with liver cirrhosis.
    Watanabe A; Nagashima H
    J Med; 1988; 19(5-6):383-93. PubMed ID: 3204331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.
    Geissler A; Lock G; Fründ R; Held P; Hollerbach S; Andus T; Schölmerich J; Feuerbach S; Holstege A
    Hepatology; 1997 Jan; 25(1):48-54. PubMed ID: 8985263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathophysiology of hepatic encephalopathy: studies in autopsied brain tissue from hepatic coma patients.
    Butterworth RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():131-6. PubMed ID: 19256152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects].
    Romero Gómez M; Bautista JD; Grande L; Ramos Guerrero RM; Sánchez Muñoz D
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():40-8. PubMed ID: 15195533
    [No Abstract]   [Full Text] [Related]  

  • 50. [Evaluation of brain evoked potentials in the detection of subclinical hepatic encephalopathy in cirrhotics].
    Ryu N; Gao W; Yan M
    No To Shinkei; 1997 Oct; 49(10):887-92. PubMed ID: 9368885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Lactulose in treatment of hepatic encephalopathy in patient with liver cirrhosis].
    Shuliat'ev IS; Il'chenko LIu; Vinnitskaia EV; Petrakov AV; Sil'verstrova SIu
    Eksp Klin Gastroenterol; 2002; (5):38-41, 127. PubMed ID: 12619575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prognostic significance of subclinical hepatic encephalopathy.
    Hartmann IJ; Groeneweg M; Quero JC; Beijeman SJ; de Man RA; Hop WC; Schalm SW
    Am J Gastroenterol; 2000 Aug; 95(8):2029-34. PubMed ID: 10950053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity?
    Cadranel JF; Lebiez E; Di Martino V; Bernard B; El Koury S; Tourbah A; Pidoux B; Valla D; Opolon P
    Am J Gastroenterol; 2001 Feb; 96(2):515-8. PubMed ID: 11232699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
    Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M
    Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Complex therapy of chronic hepatic encephalopathy supplemented with probiotic: comparison of two studies].
    Boca M; Vyskocil M; Mikulecký M; Ebringer L; Kolibás E; Kratochvíl'ová H; Buzgová D
    Cas Lek Cesk; 2004; 143(5):324-8. PubMed ID: 15305769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flumazenil in the treatment of hepatic encephalopathy in children with fulminant liver failure.
    Devictor D; Tahiri C; Lanchier C; Navelet Y; Durand P; Rousset A
    Intensive Care Med; 1995 Mar; 21(3):253-6. PubMed ID: 7790615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Flumazenil and hepatic encephalopathy.
    Amaral OB; Quevedo J; Walz R; Kapczinski F
    Hepatology; 1999 Apr; 29(4):1338-9. PubMed ID: 10336339
    [No Abstract]   [Full Text] [Related]  

  • 59. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
    Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
    Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Definitions and criteria for acute and chronic portal systemic encephalopathy].
    Valdovinos Díaz MA
    Rev Invest Clin; 1990 Jul; 42 Suppl():110-2. PubMed ID: 19256148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.